Statins Inhibit Monocyte Chemotactic Protein 1 Expression in Endometriosis
article
OA: closed
CC0
⤵ 24 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis via openalex
- Down-Regulation of Endometrial Matrix Metalloproteinase-3 and -7 Expression<i>in Vitro</i>and Therapeutic Regression of Experimental Endometriosis<i>in Vivo</i>by a Novel Nonsteroidal Progesterone Receptor Agonist, Tanaproget via openalex
- Effects of oxidants and antioxidants on proliferation of endometrial stromal cells via openalex
- Extracellularly Signal-Regulated Kinase Activity in the Human Endometrium: Possible Roles in the Pathogenesis of Endometriosis via openalex
- High-dose atorvastatin causes regression of endometriotic implants: a rat model via openalex
- Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal Fluid lnterleukin‐1β and Tumor Necrosis Factor in Patients With Benign Gynecologic Disease via openalex
- Simvastatin Induces Apoptosis and Alters Cytoskeleton in Endometrial Stromal Cells via openalex
- Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis via openalex
- Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model via openalex
- Statins Inhibit Growth of Human Endometrial Stromal Cells Independently of Cholesterol Availability1 via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis via openalex
- Uterine Chemokines in Reproductive Physiology and Pathology via openalex
- W2033705087 via openalex
- W2027236010 via openalex
- W2020504971 via openalex
- W2051877289 via openalex
- W2015629565 via openalex
- W2071124826 via openalex
- W2012105257 via openalex
- W2074996264 via openalex
- W2077792958 via openalex
- W2007954685 via openalex
- W1978366541 via openalex
- W2101397851 via openalex
- W2105291793 via openalex
- W2111778006 via openalex
- W1977595948 via openalex
- W1970106273 via openalex
- W2135087363 via openalex
- W1964923339 via openalex
- W2147718768 via openalex
- W1951308530 via openalex
- W2164830737 via openalex
- W1769068394 via openalex
- W2396032417 via openalex
- W2411065761 via openalex
- W2031379379 via openalex
- W4214726381 via openalex
Cited by (24)
- Managing endometriosis and endometriosis-linked cardiovascular disease events/risks with simvastatin-loaded self-nanoemulsifying drug delivery system in humanised endometriotic SD rat model 2026
- Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis 2023
- Immunotherapy: A promising novel endometriosis therapy 2023
- The Effect of Laparoscopic Radical Surgery for Endometriosis on Serum Levels of Lipid Profile and Vitamin D 2022
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- Monocyte chemotactic protein-1 concentrations and expression of women with endometriosis undergoing IVF cycles 2021
- Alpha-Lipoic Acid Plays a Role in Endometriosis: New Evidence on Inflammasome-Mediated Interleukin Production, Cellular Adhesion and Invasion 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- The Role of Selected Chemokines in the Peritoneal Fluid of Women with Endometriosis—Participation in the Pathogenesis of the Disease 2021
- Animal models for research on endometriosis 2020
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies 2018
- Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells 2018
- Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence 2018
- Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis 2018
- Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial 2017
- Effect of simvastatin on baboon endometriosis† 2017
- Treatment of Endometriosis with Non-Hormonal Agents: Review 2016
- Statins as Targeted “Magical Pills” for the Conservative Treatment of Endometriosis: May Potential Adverse Effects on Female Fertility Represent the “Dark Side of the Same Coin”? A Systematic Review of Literature 2015
- Management of Endometriosis 2015
- Endometriosis in Experimental Models 2014
- Macrophages in Pathophysiology of Endometriosis 2014
- Potential New Drugs for Endometriosis: Experimental Evidence 2014
- Chemokines in the pathogenesis of endometriosis and infertility 2013
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:23.388809+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK